[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"surgical-outcomes\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:surgical-outcomes":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100571508","phenol-or-laser-best-minimally-invasive-treatment-for-pilonidal-sinus-100571508",false,"NCT06721169","Phenol or Laser: Best Minimally Invasive Treatment for Pilonidal Sinus?","Minimally Invasive Treatment of Pilonidal Sinus Disease: Which is Better? Phenol or Laser Ablation","Inclusion Criteria:\n\n* Patients aged 18 years and older with pilonidal sinus disease\n* Patients who have not had any previous treatment for pilonidal sinus disease\n* Patients with uncomplicated pilonidal sinus\n* Having been diagnosed with pilonidal sinus disease\n* Patients whose descriptive and clinical characteristics are recorded in their medical files\n* Those who have signed the Informed Voluntary Consent Form\u002FWritten Consent Form\n\nExclusion Criteria:\n\n* Patients who have previously been treated for pilonidal sinus disease\n* Patients with complicated pilonidal sinus disease\n* Patients aged under 18\n* Patients whose descriptive and clinical characteristics are not recorded in their file records\n* Those who have not signed the Informed Voluntary Consent Form\u002FWritten Consent Form","ALL","18 Years",{"count":19,"type":20},64,"ESTIMATED","1 Year","OBSERVATIONAL","Pilonidal sinus disease is a common condition. There is still ongoing research on the ideal treatment. Pilonidal sinus disease is most common in men between the ages of 20 and 30. For patients with symptoms of pilonidal sinüs (pain, itching and discharge with soiling of underwear) that interfere with their normal daily life, several treatment options have emerged. A hairy body, thick skin, overweight, a deep gluteal cleft, lack of hygiene, sedentarism, repeated chafing and previous familial history are commonly admitted as predisposing factors.\n\nThere are various surgical and non-surgical methods for its treatment. Many different surgical techniques have been defined. None of these surgical techniques are defined as 'gold standard'.\n\nFor many years, wide excision and secondary healing was the standard approach for pilonidal sinus disease. However, when this method resulted in prolonged healing and restriction of regular activities, various reconstructive methods were developed to demonstrate the disadvantages of secondary healing.\n\nA minimally invasive treatment modality for pilonidal sinüs dissease is excision of the sinus pit(s) followed by application of phenol to the sinus tract. Phenol is a sclerosing agent that destroys the epithelium and debris in the sinus, and is, thus, able to promote healing of the sinus.\n\nRecently, advances in laser technology have made laser ablation of the sinus tract possible. The aim is to destroy and obliterate the sinus tracts with thermal energy produced by the laser probe.\n\nThe aim of this prospective observational study was to compare phenolization and laser ablation in the treatment of pilonidal sinus disease.",[25,26,27],"Pilonidal Sinus Treatment","Pilonidal Sinus Disorder","Surgical Outcomes",[29],"Pilonidal Disease, Phenol, Laser Ablation","RECRUITING","2026-03-23",{"date":33,"type":34},"2026-03-25","ACTUAL",{"date":36,"type":34},"2024-12-28",{"date":38,"type":20},"2026-07-15",{"name":40,"class":41},"Mersin University","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":51,"minAge":17,"maxAge":52,"enrollmentInfo":53,"targetDuration":55,"studyType":22,"phases":4,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":73},"100537548","national-robotics-assisted-radical-prostatectomy-database-100537548","NCT06279260","National Robotics-Assisted Radical Prostatectomy Database","National Robotics-Assisted Radical Prostatectomy Database: Exploring Learning Curves and Long Term Surgical, Oncological and Patient Reported Outcome Measures (PROMS)","RASOR","Inclusion Criteria:\n\nTo be eligible to participate in this database, an individual must meet all of the following criteria:\n\n1. Individuals who consent to participate,\n2. within the age range of 18 to 90 years,\n3. confirmed diagnosis of localized prostate cancer (PCa)\n4. patients receiving medical attention at hospitals engaged in collaborative efforts with the designated database.\n\nExclusion Criteria:\n\n1. Participants are not eligible to take part in the database:\n2. Individuals who have not undergone robotic surgery for prostatectomy or TP biopsy. ,\n3. without a diagnosis of prostate cancer or\n4. who decline to provide consent for the collection of their health information\n5. Under the age of 18 years.","MALE","90 Years",{"count":54,"type":20},10000,"5 Years","In Australia, nearly 70 men are diagnosed with Prostate cancer every day. Prostate removal (Radical Prostatectomy) is the proven treatment option to control cancer spread. Most of the prostate removal surgeries are done using robots. Robotic assisted prostate removal surgeries have been invented to minimise the risk of side effects post-surgery. Doctors prefer the robots over open surgery as there are benefits to patients (shorter hospital stays, lesser blood loss and better quality of life) and surgeons (better dexterity, improved field of vision and less pain). However, the cost of the robot outweighs the benefits at present and there is very less information concerning the long-term outcomes for patients.\n\nStudies conducted so far are small scale studies and the results from these studies cannot be generalized to the population at large in Australia. So, there is need for a largescale study that will look at the long-term outcomes and the factors that impact robotic surgeries across the metropolitan and rural hospital sectors.\n\nHence, this comprehensive database has been setup to collaborate with major hospitals, across metropolitan and rural areas in Australia. Through this database, researchers will be able to explore the diagnostic pathway for Prostate cancer and understand the long-term benefits of robotic surgery through patient reported questionnaires. Outcomes from this database will also help compare the quality of care against other powerhouses of robotic surgery.\n\nEventually, the database aims to standardize diagnostic pathways and clinical notes that are the same across different hospitals conducting robotic-assisted surgeries for Prostatectomy and improve care for prostate cancer patients across the country.",[58,59,60,27,61,62,63],"Database","Prostate Cancer","Robotic-assisted Radical Prostatectomy","Oncological Outcomes","Patient Reported Outcome Measures","Learning Curve","2024-08-22",{"date":66,"type":34},"2024-08-26",{"date":68,"type":34},"2024-07-01",{"date":70,"type":20},"2050-12",{"name":72,"class":41},"Melbourne Health",8]